Abeona Therapeutics Inc (NAS:ABEO)
$ 4.3701 0.1701 (4.05%) Market Cap: 178.51 Mil Enterprise Value: 126.38 Mil PE Ratio: 0 PB Ratio: 7.80 GF Score: 45/100

Q1 2020 Abeona Therapeutics Inc Earnings Call Transcript

May 07, 2020 / 12:30PM GMT
Release Date Price: $58.25 (-4.12%)
Operator

Good day, and welcome to the Abeona Therapeutics First Quarter 2020 Financial Results and Business Update Conference Call. (Operator Instructions) As a reminder, today's conference is being recorded.

I will now introduce your host for today's conference, Greg Gin, Vice President of Investor Relations at Abeona. Please go ahead, sir.

Gregory Gin
Abeona Therapeutics Inc. - Head of IR

Thank you, operator. Good morning and welcome, everyone. Today's call will be held by João Siffert, our Chief Executive Officer. Following João's remarks, our Chief Accounting Officer, Ed Carr, will review our financials.

Before I turn the call over to them, I need to remind our listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in these statements is based on current expectations and is subject to change, and actual results may differ materially from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot